These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 23770658)
21. Profiles of macular pigment optical density and their changes following supplemental lutein and zeaxanthin: new results from the LUNA study. Zeimer M; Dietzel M; Hense HW; Heimes B; Austermann U; Pauleikhoff D Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4852-9. PubMed ID: 22743321 [TBL] [Abstract][Full Text] [Related]
22. The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype. Loane E; Nolan JM; McKay GJ; Beatty S Exp Eye Res; 2011 Nov; 93(5):592-8. PubMed ID: 21816153 [TBL] [Abstract][Full Text] [Related]
23. Macular pigment optical density at four retinal loci during 120 days of lutein supplementation. Wenzel AJ; Sheehan JP; Gerweck C; Stringham JM; Fuld K; Curran-Celentano J Ophthalmic Physiol Opt; 2007 Jul; 27(4):329-35. PubMed ID: 17584283 [TBL] [Abstract][Full Text] [Related]
24. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124 [TBL] [Abstract][Full Text] [Related]
25. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision. Rodriguez-Carmona M; Kvansakul J; Harlow JA; Köpcke W; Schalch W; Barbur JL Ophthalmic Physiol Opt; 2006 Mar; 26(2):137-47. PubMed ID: 16460314 [TBL] [Abstract][Full Text] [Related]
26. Macular pigment optical density in a South Indian population. Raman R; Rajan R; Biswas S; Vaitheeswaran K; Sharma T Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):7910-6. PubMed ID: 21849422 [TBL] [Abstract][Full Text] [Related]
27. Macular pigment optical density spatial distribution measured in a subject with oculocutaneous albinism. Putnam CM; Bland PJ J Optom; 2014; 7(4):241-5. PubMed ID: 25323647 [TBL] [Abstract][Full Text] [Related]
28. Effects of a lutein supplement on the plasma lutein concentration and macular pigment in patients with central serous chorioretinopathy. Sawa M; Gomi F; Hara C; Nishida K Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5238-44. PubMed ID: 25074771 [TBL] [Abstract][Full Text] [Related]
29. Macular pigment optical density in young adults of South Asian origin. Howells O; Eperjesi F; Bartlett H Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2711-9. PubMed ID: 23471890 [TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E genotype is associated with macular pigment optical density. Loane E; McKay GJ; Nolan JM; Beatty S Invest Ophthalmol Vis Sci; 2010 May; 51(5):2636-43. PubMed ID: 20107178 [TBL] [Abstract][Full Text] [Related]
31. The role of macular pigment assessment in clinical practice: a review. Bartlett H; Howells O; Eperjesi F Clin Exp Optom; 2010 Sep; 93(5):300-8. PubMed ID: 20629669 [TBL] [Abstract][Full Text] [Related]
32. The association between dark adaptation and macular pigment optical density in healthy subjects. Patryas L; Parry NR; Carden D; Aslam T; Murray IJ Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):657-63. PubMed ID: 24413682 [TBL] [Abstract][Full Text] [Related]
33. The effect of age and cataract surgery on macular pigment optic density: a cross-sectional, comparative study. Demirel S; Bilici S; Batıoglu F; Ozmert E Graefes Arch Clin Exp Ophthalmol; 2014 Feb; 252(2):213-8. PubMed ID: 23873256 [TBL] [Abstract][Full Text] [Related]
34. The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case-control and case study designs. Renzi LM; Hammond BR; Dengler M; Roberts R Lipids Health Dis; 2012 Feb; 11():33. PubMed ID: 22375926 [TBL] [Abstract][Full Text] [Related]
35. Comparison of macular pigment in patients with age-related macular degeneration and healthy control subjects - a study using spectral fundus reflectance. Kaya S; Weigert G; Pemp B; Sacu S; Werkmeister RM; Dragostinoff N; Garhöfer G; Schmidt-Erfurth U; Schmetterer L Acta Ophthalmol; 2012 Aug; 90(5):e399-403. PubMed ID: 23035764 [TBL] [Abstract][Full Text] [Related]
36. Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD). Tsika C; Tsilimbaris MK; Makridaki M; Kontadakis G; Plainis S; Moschandreas J Acta Ophthalmol; 2011 Nov; 89(7):e573-8. PubMed ID: 21672183 [TBL] [Abstract][Full Text] [Related]
37. Two-wavelength fundus autofluorescence and macular pigment optical density imaging in diabetic macular oedema. Waldstein SM; Hickey D; Mahmud I; Kiire CA; Charbel Issa P; Chong NV Eye (Lond); 2012 Aug; 26(8):1078-85. PubMed ID: 22699976 [TBL] [Abstract][Full Text] [Related]
38. Macular Pigment Response to Lutein, Zeaxanthin, and Meso-zeaxanthin Supplementation in Open-Angle Glaucoma: A Randomized Controlled Trial. Loughman J; Loskutova E; Butler JS; Siah WF; O'Brien C Ophthalmol Sci; 2021 Sep; 1(3):100039. PubMed ID: 36247822 [TBL] [Abstract][Full Text] [Related]
39. Fluorescence lifetime imaging ophthalmoscopy and the influence of oral lutein/zeaxanthin supplementation on macular pigment (FLOS) - A pilot study. Jaggi D; Solberg Y; Dysli C; Lincke J; Habra O; Wyss A; Wolf S; Zinkernagel M Clin Nutr ESPEN; 2023 Aug; 56():127-134. PubMed ID: 37344061 [TBL] [Abstract][Full Text] [Related]